Xiao-Ming Mao: Clinical Trials

3 trials sponsored by Xiao-Ming Mao, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting. 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 41Completed 1

Follow Xiao-Ming Mao: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
Graves Disease, Graves' Disease in Remission
Not yet recruitingXiao-Ming Mao3002024-05-302024-05-23
Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients
Dexamethasone - Graves' Disease
Phase 1CompletedXiao-Ming Mao502012-03-012012-11-12
Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone
MMI combined with IID, MMI - Graves' Disease
Phase 4CompletedXiao-Ming Mao2182004-06-012013-05-06

Conditions studied

Graves Disease (3)  ·  Epstein-Barr Virus Infections (1)  ·  Recurrence (1)

Interventions

Dexamethasone (1)  ·  Methimazole (1)

Countries

China (2)

Top investigators

Xiaoming Mao, M.D. (1)

Results publications

PMID 19850691, PMID 22219499